HDAC7 and ovarian carcinoma: HDAC7 inhibition significantly suppressed growth and invasion of the ovarian cancer cells in vitro and depressed tumour growth in vivo, suggesting that HDAC7 has a significant contribution in ovarian cancer progression and may function as an oncogenic driver of ovarian cancer.